Tristan J Hynes - Publications

Affiliations: 
University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Behavioural Neuroscience

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Chernoff CS, Hynes TJ, Schumacher JD, Ramaiah S, Avramidis DK, Mortazavi L, Floresco SB, Winstanley CA. Noradrenergic regulation of cue-guided decision making and impulsivity is doubly dissociable across frontal brain regions. Psychopharmacology. PMID 38001266 DOI: 10.1007/s00213-023-06508-2  0.655
2023 Hynes TJ, Chernoff CS, Hrelja KM, Tse MTL, Avramidis DK, Lysenko-Martin MR, Calderhead L, Kaur S, Floresco SB, Winstanley CA. Win-Paired Cues Modulate the Effect of Dopamine Neuron Sensitization on Decision Making and Cocaine Self-administration: Divergent Effects Across Sex. Biological Psychiatry. PMID 37673411 DOI: 10.1016/j.biopsych.2023.08.021  0.671
2023 Zumbusch A, Samson A, Chernoff C, Coslovich B, Hynes T. Biological sex influences the contribution of sign-tracking and anxiety-like behavior toward remifentanil self-administration. Behavioral Neuroscience. PMID 36780278 DOI: 10.1037/bne0000551  0.716
2023 Mortazavi L, Hynes TJ, Chernoff CS, Ramaiah S, Brodie HG, Russell B, Hathaway BA, Kaur S, Winstanley CA. D Agonist during Learning Potentiates Cued Risky Choice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36623876 DOI: 10.1523/JNEUROSCI.1459-22.2022  0.722
2021 Chernoff CS, Hynes TJ, Winstanley CA. Noradrenergic contributions to cue-driven risk-taking and impulsivity. Psychopharmacology. PMID 33649970 DOI: 10.1007/s00213-021-05806-x  0.601
2021 Betts GD, Hynes TJ, Winstanley CA. Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task. Journal of Psychopharmacology (Oxford, England). 269881120972421. PMID 33573446 DOI: 10.1177/0269881120972421  0.692
2021 Hynes TJ, Hrelja KM, Hathaway BA, Hounjet CD, Chernoff CS, Ebsary SA, Betts GD, Russell B, Ma L, Kaur S, Winstanley CA. Dopamine neurons gate the intersection of cocaine use, decision making, and impulsivity. Addiction Biology. e13022. PMID 33559379 DOI: 10.1111/adb.13022  0.752
2020 Russell B, Barrus MM, Tremblay M, Ma L, Hrelja K, Wong C, Hynes TJ, Hobson S, Grottick AJ, Winstanley CA. GPR52 agonists attenuate ropinirole-induced preference for uncertain outcomes. Behavioral Neuroscience. PMID 33119328 DOI: 10.1037/bne0000391  0.646
2020 Hynes TJ, Ferland JM, Feng TL, Adams WK, Silveira MM, Tremblay M, Chernoff CS, Brodie HG, Ebsary SA, Russell B, Kaur S, Winstanley CA. Chemogenetic inhibition of dopaminergic projections to the nucleus accumbens has sexually dimorphic effects in the rat gambling task. Behavioral Neuroscience. PMID 32525335 DOI: 10.1037/Bne0000372  0.734
2019 Ferland JN, Hynes TJ, Hounjet CD, Lindenbach D, Vonder Haar C, Adams WK, Phillips AG, Winstanley CA. Prior exposure to salient win-paired cues in a rat gambling task increases sensitivity to cocaine self-administration and suppresses dopamine efflux in nucleus accumbens: support for the reward deficiency hypothesis of addiction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30626700 DOI: 10.1523/Jneurosci.3477-17.2018  0.801
2019 Hynes TJ, Hathaway BA, Hrelja KM, Ebsary SA, Chernoff CS, Ma L, Russell B, Kaur S, Winstanley CA. Chemogenetic inhibition of ventral tegmental dopamine neurons prevents cocaine-induced deficits in decision making in both sexes Pharmacological Reports. 71: 1310. DOI: 10.1016/J.Pharep.2019.09.008  0.698
2017 Hynes TJ, Thomas CS, Zumbusch AS, Samson A, Petriman I, Mrdja U, Orr A, Cutts E, Ruzindana BG, Hazari A, Zjadewicz M, Lovic V. Early life adversity potentiates expression of addiction-related traits. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28899646 DOI: 10.1016/J.Pnpbp.2017.09.005  0.601
Show low-probability matches.